Electrophoresis Market 2019 Segments, Trends, Share and Forecast Growth

Electrophoresis is an analytical method frequently used in nucleic acid and protein analysis to separate macromolecules such as DNA, RNA, and proteins based on their size and charge. This technology is extensively used in the fields of medical diagnostics, life sciences, and clinical research.

A number of factors, such as the growth in funding for research on electrophoresis techniques, increasing number of research collaborations between market players and academic institutions, increasing use of capillary electrophoresis (CE) with mass spectroscopy (MS), and growing focus on next-generation sequencing research are driving the growth of the electrophoresis market.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=434

The growth of this market is majorly driven by the increasing research activities in the fields of proteomics and genomics, changing regulatory requirements in the pharmaceutical sector, and the growing need to curtail healthcare costs.

key players operating in the Global Electrophoresis Market;

The prominent players in the global electrophoresis market are Bio-Rad Laboratories (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Merck Millipore (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Lonza Group Ltd. (Switzerland), Shimadzu Corporation (Japan), Harvard Bioscience, Inc. (U.S.), Sebia Group (U.K.), and C.B.S. Scientific Company, Inc. (U.S.).

Major Drivers Impacting the Electrophoresis Market;

· Rising Incidence of Cancer, Infectious Diseases, and Genetic Disorders

· Growth in Funding for Research on Genomic, Proteomic, and Electrophoresis Techniques

· Growing Number of Industry-Academia Research Collaborations

· Growing Use of Capillary Electrophoresis with Mass Spectroscopy

· Growing Use of Next-Generation Sequencing

· Rapid Growth in Aging Population

· Growth in the Number of Clinical, Forensic, and Research Laboratories

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=434

Global Electrophoresis Market Segmentation:

Based on application, the electrophoresis market is categorized into research, diagnostics, and quality control & process validation. the research applications segment accounted for the largest share of the market.

Based on Region, North America accounted for the largest share of the electrophoresis market, followed by Europe and Asia-Pacific. The patent expiration of several blockbuster drugs of major pharmaceutical companies is, in turn, increasing investments for new drug discovery; this is a key market driver in North America.

Major Key Points From TOC:

· Global Electrophoresis Market Size, By Application (USD Million)

· Global Electrophoresis Market Size, By End User (USD Million)

· Geographic Snapshot of the Global Electrophoresis Market

· Rising Incidence of Chronic Diseases–Key Factor Driving Global Market Growth

· Developing Markets to Register Higher Growth in the Forecast Period

Metabolomics Market | Business Overview, Products and Services, Key Insights, Recent Developments

Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface-based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors) — Forecast

The metabolomics market majorly comprises detection techniques such as mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR), and separation techniques such as gas chromatography. These techniques are used in metabolome studies, primarily in toxicology testing and developing personalized medicine.

Download PDF (Metabolomics Market):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218189007

This research report segments this Metabolomics Market based on product and service, application, indication, and region.

Major Market Drivers in Metabolomics Market:

• Availability of government and private funding
• Increasing pharmaceutical and biotech R&D expenditure
• Technological advancements
• Growing demand for personalized medicine
• Increasing the use of metabolomics in toxicology testing

Key Questions Addressed in the Research Study:

• Metabolomics helps identify the type and number of compounds analyzed by making use of several complementary analytical methods and what would be the future of metabolomics instruments in the upcoming years?
• How growing demand for personalized medicine and other factors would change the future of the metabolomics market?

Request Research Sample Pages (Metabolomics Market):

https://www.marketsandmarkets.com/requestsampleNew.asp?id=900

Key Market Growth Trend in Metabolomics:

The growing use of hyphenated technologies is likely to provide the largest growth opportunity for metabolomics market players.

Over the past four years, several hyphenated systems have been launched by market players. Hyphenated technology is a combination of two or more analytical tools. Hyphenated technologies reduce cost by requiring the installation of a single instrument. They also provide ease of operation and require lesser space as compared to the installation of two or more standalone devices. In addition, these technologies have broadened the applications of analytical techniques in the analysis of biomaterials, especially natural products.

Major Key Players in Metabolomics Market;

Prominent players in the global metabolomics market are Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), and Shimadzu Corporation (Japan). Other leading players in this market include Bio-Rad Laboratories (U.S.), Bruker Corporation (U.S.),

Rat Model Market Research, In-Depth Analysis, Key Players, Forecast

According to the new market research report “Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User -Global Forecast”, published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

The Global Rat Model Market is expected to reach $588.9 Million, growing at a CAGR of 8.7%

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76036494

The global rat model market is segmented on the basis of model type, service, therapeutic area, technology, end user, care product, and region.

On the basis of model type, the market is categorized into outbred rat, inbred rats, knockout/genetically modified rats, conditioned/surgically modified rats, hybrid/congenic rats, and immunodeficient rats. In 2016, the outbred rats segment is estimated to account for the largest share of the global rat model market. However, the knockout/genetically modified rats segment is expected to be the fastest-growing segment owing to the use of this type of rat models to carry out researches on disease such as oncology, obesity, heart disease, diabetes, arthritis, drug abuse, anxiety, aging, and Parkinson’s disease.

Browse and in-depth TOC on “Rat Model Market”

132 — Tables

47 — Figures

253 — Pages

On the basis of technology, the market is segmented into CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies (genetically modified sperm-mediated gene transfer, virus/vector mediated gene transfer, liposome-mediated DNA & electroporation of DNA, biolistics, and TALENs & ZFN). In 2016, the CRISPR segment is expected to command the largest share of the global rat model market.

On the basis of therapeutic area, the market is segmented into toxicology, oncology, immunology & inflammation, diabetes, neurology, and other therapeutic areas (rare diseases, cardiovascular diseases, metabolic diseases, hematopoiesis, and renal disorders). In 2016, the toxicology segment is expected to command the largest share of the global rat model market.

Charles River Laboratories International, Inc. (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (U.K.), Laboratory Corporation of America Holdings (U.S.), Biomere (U.S.), Janvier Labs (France), genOway SA (France), and Horizon Discovery Group plc (U.K.) are some of the key players in the rat model market worldwide.

Read More in Detailed:https://www.marketsandmarkets.com/PressReleases/rat-model.asp

sugar excipients Market Research Report 2019 By Key players and Growth Rate

The Research Report on Sugar excipients Market, which Contains 125 market data tables and 34 figures spread through 187 pages and in-depth TOC, covers Global Market overview.

Major Key Players detailed Analysis, market opportunities, market risk, the forecast for the next five years, major driving factors for the market as well as detailed analysis for CAGR, scope, research findings, leading key players marketing strategy to acquire major market in the form of revenue.

Download PDF (Sugar-Based Excipients Market):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218189007

Research Report segments the Sugar excipients Market based on product, type, functionality, formulation, and region.

However, stringent regulatory requirements leading to a short age of FDA-approved manufacturing sites can hinder their market growth to a certain extent.

Sugar excipients Market Based on Product;

On the basis of product, the global market is segmented into actual sugars, sugar alcohols, and artificial sweeteners. the actual sugar segment accounted for the largest share of the market. The large share of this segment is primarily attributed to its high utilization in oral formulations and pediatric formulations due to its non-toxicity and negligible reaction with drugs.

Speak to Our Subject Expert:https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=242342136

Sugar excipients Market Based on Type;

Based on type, the market is segmented into powders/granules, direct compression sugars, crystals, and syrups. The powders/granules segment accounted for the largest share of global sugar excipients market. The large share of the powders/granules segment is mainly attributed to its wide use in various types of formulations in the pharmaceutical industry.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=242342136

Major Key Players Operating in Global Sugar excipients Market:

Roquette Group (France), DFE Pharma (Germany), BASF SE (Germany), and Ashland Inc. (U.S.), held the major share of the sugar excipients market, and are expected to dominate the market during the forecast period.

The leading position of Roquette Group (France) in this market is primarily attributed to its strong presence in the sugar excipients market with a broad spectrum of products with proven effectiveness. The company operates its business across more than 100 countries worldwide. It emphasizes on increasing its market presence and geographical network majorly through expansions and acquisitions.

European Hemostats and Sealants Market size, Industry Analysis and Forecast to 2024

The Global European Hemostats and Sealants Market are projected to reach USD 89 million by 2024 from USD 63 million in 2019, at a CAGR of 7.0%.

Hemostats help in controlling bleeding at the site of a wound or performing various open surgeries. The different types of products used include thrombin-based hemostats, combination hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, and collagen-based hemostats. Of these, combination hemostats are anticipated to grow at the highest rate in Europe, as they reduce the risk of side-effects post-application.

Download PDF: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=115823197

European Hemostats and Sealants Market segmentation:

· based on products

· based on regions.

The Major Players Operating in the European Hemostats and Sealants Market:

Key players operating in the Hemostats and Sealants (focused products) market include B. Braun (Germany), Medtronic (Ireland), C. R. Bard (US), Takeda (Japan), and Baxter (US).

Hemostats and Sealants Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the European Hemostats and Sealants (focused products) market. The research methodology used to estimate the market size includes the following:

• The key players in the industry and markets have been identified through extensive secondary research
• The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research

Speak to Our Research Expert:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=115823197

Geographical Detailed Analysis for European Hemostats and Sealants Market:

Germany commands the largest share of the market

Based on region, the Hemostats and Sealants (focused products) market is segmented into Germany, the UK, France, Italy, and Spain. Germany dominates the Hemostats and Sealants market due to its large patient population and the favorable reimbursement scenario for the usage of hemostats.

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=115823197

Key questions addressed in the report:

• What are the growth opportunities in the Hemostats and Sealants market across major countries in Europe in the future?
• What are the key drivers and restraints in the Hemostats and Sealants market?
• What are the key brands in the Hemostats and Sealants market?
• Which are the key countries in the Hemostats and Sealants market?
• What are the most preferred brands amongst end users?

Prefilled Syringes Market Projected to reach US $ 6.36 Billion

The rising demand for prefilled syringes can be attributed to the growing prevalence of chronic diseases, technological advancements, rising adoption of self-injecting parenteral devices, and implementation of needlestick legislation.

Development of technologically advanced prefilled syringes and growing adoption of self-injection devices are the major trends in the prefilled syringes market. Key players in the prefilled syringes market are focusing on expanding their product portfolio with technologically advanced products in order to cater to the growing demand of these devices across the globe.

Speak to our analyst and gain crucial industry insights that will help your business grow:

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=16618331

The global prefilled syringes market is expected to reach USD 6.36 Billion, at CAGR of 10.1%

Major Drivers For Prefilled Syringes Market:

· Technological Advancements

· High Prevalence of Chronic Diseases

· Benefits Associated With Prefilled Syringes

· Rising Adoption of Self-Injection Devices

· Implementation of Needlestick Legislations

· Product Lifecycle Management Through Device Customization

On the basis of material, the global prefilled syringes market is divided into two broad segments, namely, glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment is expected to account for the largest share of the market. The growth of this segment can be attributed to the high use of glass in manufacturing syringes owing to its nonreactive nature and heat and chemical resistance.

Browse and in-depth TOC on “Prefilled Syringes Market”

85 — Tables

41 — Figures

130 — Pages

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=16618331

On the basis of type, the prefilled syringes market is segmented into conventional prefilled syringes and safety prefilled syringes. The conventional prefilled syringes segment is expected to account for the largest share during the forecast period. This growth can be primarily attributed to the comparatively low penetration of safety syringes.

Europe is expected to hold the largest share of the global prefilled syringes market, followed by North America. However, the Asia-Pacific market is expected to grow at the highest CAGR. 

Request for Free Sample Report @https://www.marketsandmarkets.com/requestsample.asp?id=16618331

Becton, Dickinson and Company (U.S.), Gerresheimer (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Ompi (Italy), Catalent, Inc. (U.S.), Weigao Group (China), Vetter Pharma International GmbH (Germany)

Global Surface Disinfectant Market Size, and Growth Projection

Surface disinfectant is used to prevent microbial cross-contamination and transmission of microbial infections through surfaces in hospitals, pathology labs, and other patient-related areas. The in-house application segment accounted for the largest share of the market.

[148 Pages Report] The overall Surface Disinfectant Market is projected to reach USD 789.1 million, at a CAGR of 8.3%

Speak to our analyst and gain crucial industry insights that will help your business grow:

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=231286043

The Major Objectives Of the Study:

• To define, describe, and forecast the Surface Disinfectant Market on the basis of type, formulation, application, end user, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and challenges)
• To analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders
• To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)

Browse and in-depth TOC on “ Surface Disinfectant Market “

102 — Tables

34 — Figures

148 — Pages

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231286043

Growth in the number of surgical procedures drives the global surface disinfectant market

Globally, the number of surgeries has increased over the last decade majorly due to the increasing prevalence of chronic diseases and growth in the geriatric population. According to the Healthcare Cost and Utilization Project (HCUP), in 2012, a total of 9.7 million procedures were performed in inpatient hospital settings and 9.3 million in outpatient hospital settings in the U.S. The volume of endoscopic minimally invasive surgeries has witnessed a steady growth over the last decade.

According to the CDC, in 2013, a total of 1.1 million small intestine endoscopic surgeries (with or without biopsy) and 499,000 large intestine endoscopic surgeries (with or without biopsy) were performed in the U.S. To eliminate the risk of infections during and after surgical procedures, high-level disinfectants are used to disinfect surgical equipment, operation theaters, and recuperation rooms.

Major Market Developments:

• In February 2017, the 3M Company (US) launched the 3M Curos Stopper disinfecting caps. This cap protects the port of instrument from contamination.
• In January 2017, Sealed Air Corporation (US) opened an R&D facility for fabric care and food and beverage hygiene solutions in India.
• In January 2017, Sealed Air Corporation (US) launched Oxivir 1 Disinfectant Cleaner and in October 2016 launched Avert Sporicidal Disinfectant Cleaner wipes. In July 2014, Company acquired Virox Technologies (Canada).
• In 2017, The Clorox Company (US) launched Clorox Healthcare Hydrogen Peroxide Cleaner Disinfectants and Clorox Healthcare Bleach Germicidal Wipes.

Request for Free Sample Report @

https://www.marketsandmarkets.com/requestsample.asp?id=231286043

Instruments Disinfection-

Instruments used in hospital care, such as endoscopes, catheters, and ventilators, can be a key cause of HAIs, and as such need to be effectively disinfected before use. Surface disinfectants used in this application segment can be either bactericidal, fungicidal, or viricidal. They are ready to use, non-toxic, and appropriate for surfaces like stainless steel, chrome, glass, plastic, and plexiglass. Formaldehyde, peracetic acid, and quaternary ammonium compounds are most commonly used for instrument disinfection.

Key players operating in the Surface Disinfectant Market include 3M Company (U.S.), Cantel Medical Corporation (U.S.), Johnson & Johnson (U.S.), Procter and & Gamble (U.S.), Reckitt Benckiser Group plc. (U.K.), The Clorox Company (U.S.), and Sealed Air Corporation (U.S.).